Lb Pharmaceuticals LBRX
NASDAQ LBRX
$40.39 -0.61 (-1.49%)
As of: Oct 21, 2026 · 12:58 PM EDT

Lb Pharmaceuticals (LBRX) EBT (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported EBT of -$51.6 million for Q2 2026, compared with -$4.87 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EBT (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lb Pharmaceuticals' EBT came in at -$85.68 million; for FY2025, it was -$25.2 million.

  • By year, EBT came in at -$63.1 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly EBT in data going back to Q3 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$19.05 million (Q1 2026), -$11.47 million (Q4 2025) and -$3.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 6.75 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 4.28 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 2.80 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn -10.25 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -653.00 Mn
10 Lb Pharmaceuticals 1.22 Bn -85.85 Mn - -51.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.60 Mn
Mar 31, 2026 -19.05 Mn
Dec 31, 2025 -11.47 Mn
Sep 30, 2025 -3.56 Mn
Jun 30, 2025 -4.87 Mn
Mar 31, 2025 -5.31 Mn
Dec 31, 2024 -5.07 Mn
Sep 30, 2024 -14.18 Mn
API Access

Lb Pharmaceuticals EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=LBRX&period=max&api_key=YOUR_API_KEY